Veru (VERU) Accounts Payables (2010 - 2026)
Veru (VERU) posted quarterly Accounts Payables of $2.1 million for Q1 2026, down 6.07% year-over-year from $2.2 million in Q1 2025, and up 36.64% quarter-over-quarter from $1.5 million in Q4 2025.
Veru (VERU) Accounts Payables (2010 - 2026) Analysis & Trends
Veru (VERU) has reported Accounts Payables for 17 consecutive years, with $2.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables fell 6.07% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $2.1 million (down 6.07% YoY), while the FY2025 annual figure was $3.1 million, up 38.14% from the prior year.
- Accounts Payables improved to $2.1 million in Q1 2026 per VERU's latest filing, from $1.5 million in the prior quarter.
- Across five years, Accounts Payables topped out at $22.0 million in Q3 2022 and bottomed at $1.5 million in Q4 2025.
- Historically, Accounts Payables has averaged $7.3 million across 5 years, with a median of $3.1 million in 2025.
- Annual changes were most pronounced in 2022 — Accounts Payables surged 545.3% — and 2024, when it plunged 85.7%.
- Veru's Accounts Payables stood at $10.6 million in 2022, then fell by 0.46% to $10.5 million in 2023, then sank by 81.04% to $2.0 million in 2024, then retreated by 23.99% to $1.5 million in 2025, then soared by 36.64% to $2.1 million in 2026.
- Business Quant data shows VERU's Accounts Payables at $2.1 million in Q1 2026, $1.5 million in Q4 2025, and $3.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Veru | 60.85 Mn | 35.06 Mn | - | 1.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.71 Mn |
| Mar 31, 2026 | 2.07 Mn |
| Dec 31, 2025 | 1.52 Mn |
| Sep 30, 2025 | 3.12 Mn |
| Jun 30, 2025 | 2.54 Mn |
| Mar 31, 2025 | 2.21 Mn |
| Dec 31, 2024 | 1.99 Mn |
| Sep 30, 2024 | 2.26 Mn |
| Jun 30, 2024 | 3.02 Mn |
| Mar 31, 2024 | 2.46 Mn |
| Dec 31, 2023 | 10.52 Mn |
| Sep 30, 2023 | 12.93 Mn |
| Jun 30, 2023 | 15.94 Mn |
| Mar 31, 2023 | 17.24 Mn |
| Dec 31, 2022 | 10.57 Mn |
| Sep 30, 2022 | 22.00 Mn |
| Jun 30, 2022 | 6.94 Mn |
| Mar 31, 2022 | 7.52 Mn |
| Dec 31, 2021 | 4.09 Mn |
| Sep 30, 2021 | 3.41 Mn |